Medical Facilities (DR) Competitors

Extendicare (TSE:EXE) and Medical Facilities (TSE:DR) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, earnings, institutional ownership, risk, media sentiment, dividends, analyst recommendations, community ranking and profitability.

Is EXE or DR a better dividend stock?

Extendicare pays an annual dividend of C$0.48 per share and has a dividend yield of 6.6%. Medical Facilities pays an annual dividend of C$0.32 per share and has a dividend yield of 2.9%. Extendicare pays out 120.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Medical Facilities pays out 32.0% of its earnings in the form of a dividend.

Does the media refer more to EXE or DR?

In the previous week, Medical Facilities had 30 more articles in the media than Extendicare. MarketBeat recorded 30 mentions for Medical Facilities and 0 mentions for Extendicare. Medical Facilities' average media sentiment score of 0.00 beat Extendicare's score of -0.08 indicating that Extendicare is being referred to more favorably in the media.

Company	Overall Sentiment
Extendicare	Neutral
Medical Facilities	Neutral

Do insiders & institutionals have more ownership in EXE or DR?

21.2% of Extendicare shares are owned by institutional investors. Comparatively, 4.8% of Medical Facilities shares are owned by institutional investors. 13.6% of Extendicare shares are owned by insiders. Comparatively, 0.4% of Medical Facilities shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Is EXE or DR more profitable?

Medical Facilities has a net margin of 4.15% compared to Medical Facilities' net margin of 2.60%. Extendicare's return on equity of 37.77% beat Medical Facilities' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Extendicare	2.60%	36.03%	6.84%
Medical Facilities	4.15%	37.77%	11.45%

Which has preferable earnings & valuation, EXE or DR?

Extendicare has higher revenue and earnings than Medical Facilities. Medical Facilities is trading at a lower price-to-earnings ratio than Extendicare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Extendicare	C$1.30B	0.47	C$33.98M	C$0.40	18.25
Medical Facilities	C$445.58M	0.60	C$18.50M	C$1.00	10.86

Do analysts recommend EXE or DR?

Extendicare currently has a consensus target price of C$7.88, suggesting a potential upside of 7.88%. Medical Facilities has a consensus target price of C$12.00, suggesting a potential upside of 10.50%. Given Extendicare's higher probable upside, analysts clearly believe Medical Facilities is more favorable than Extendicare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Extendicare	0 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.40
Medical Facilities	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00

Does the MarketBeat Community prefer EXE or DR?

Medical Facilities received 152 more outperform votes than Extendicare when rated by MarketBeat users. Likewise, 61.46% of users gave Medical Facilities an outperform vote while only 49.19% of users gave Extendicare an outperform vote.

Company	Underperform	Outperform
Extendicare	Outperform Votes 151 49.19%	Underperform Votes 156 50.81%
Medical Facilities	Outperform Votes 303 61.46%	Underperform Votes 190 38.54%

Which has more risk & volatility, EXE or DR?

Extendicare has a beta of 1.22, meaning that its share price is 22% more volatile than the S&P 500. Comparatively, Medical Facilities has a beta of 0.59, meaning that its share price is 41% less volatile than the S&P 500.

Summary

Extendicare and Medical Facilities tied by winning 10 of the 20 factors compared between the two stocks.